Associations of polymorphisms in the candidate genes for Alzheimer's disease BIN1, CLU, CR1 and PICALM with gestational diabetes and impaired glucose tolerance

. 2017 Apr ; 44 (2) : 227-231. [epub] 20170318

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid28316001
Odkazy

PubMed 28316001
DOI 10.1007/s11033-017-4100-9
PII: 10.1007/s11033-017-4100-9
Knihovny.cz E-zdroje

Alzheimer's disease (AD) is the most common type of dementia, with a prevalence that is rising every year. AD is associated with type 2 diabetes mellitus (T2DM) and insulin resistance, and is therefore sometimes called "type 3 diabetes mellitus". The aim of this study was to examine whether the variants of some candidate genes involved in the development of AD, namely BIN1 (rs744373), CLU (rs11136000), CR1 (rs3818361), and PICALM (rs3851179), are related to several disorders of glucose metabolism-gestational diabetes (GDM), T2DM and impaired glucose tolerance (IGT). Our study included 550 women with former GDM and 717 control women, 392 patients with T2DM and 180 non-diabetic controls, and 117 patients with IGT and 630 controls with normal glucose tolerance. Genotyping analysis was performed using specially-designed TaqMan assays. No significant associations of the genetic variants rs744373 in BIN1, rs11136000 in CLU, or rs3818361 in CR1 were found with GDM, T2DM or IGT, but rs3851179 in PICALM was associated with an increased risk of GDM. The frequency of the AD risk-associated C allele was significantly higher in the GDM group compared to controls: OR 1.21; 95% CI (1.03-1.44). This finding was not apparent in T2DM and IGT; conversely, the C allele of the PICALM SNP was protective for IGT: OR 0.67; 95% CI (0.51-0.89). This study demonstrates an association between PICALM rs3851179 and GDM as well as IGT. However, elucidation of the possible role of this gene in the pathogenesis of GDM requires further independent studies.

Zobrazit více v PubMed

Arch Neurol. 2008 Mar;65(3):329-34 PubMed

Transl Psychiatry. 2012 May 15;2:e117 PubMed

PLoS One. 2015 Jun 15;10(6):e0129776 PubMed

Int J Biochem Cell Biol. 2009 Jun;41(6):1261-8 PubMed

Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):821-33 PubMed

J Alzheimers Dis. 2005 Feb;7(1):63-80 PubMed

J Alzheimers Dis. 2005 Dec;8(3):247-68 PubMed

Nat Genet. 2009 Oct;41(10):1088-93 PubMed

Nat Rev Neurosci. 2007 Sep;8(9):663-72 PubMed

Neurobiol Aging. 2014 Apr;35(4):777-85 PubMed

J Nat Sci Biol Med. 2013 Jul;4(2):302-5 PubMed

Int J Environ Res Public Health. 2016 Jul 28;13(8):null PubMed

Nat Genet. 2009 Oct;41(10):1094-9 PubMed

JAMA. 2010 May 12;303(18):1832-40 PubMed

J Alzheimers Dis. 2005 Feb;7(1):45-61 PubMed

Arch Med Res. 2012 Nov;43(8):622-31 PubMed

Alzheimers Dement (Amst). 2015 Dec;1(4):395-402 PubMed

Diabet Med. 2016 Sep;33(9):1211-21 PubMed

PLoS One. 2012;7(8):e44252 PubMed

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...